Search results for: “biotech”
-
BSF and CellRev join forces to create a new Foodtech company for cultivated meat
•
LONDON: BSF, a biotech company that owns two tissue engineering companies, 3D Bio-Tissues and Kerato, has announced a…
-
Roche signs deal to acquire Schroders’s Carmot Therapeutics for upto $3.1 billion
•
LONDON, UK: Schroders Capital’s portfolio company Carmot Therapeutics Inc. has entered into a definitive agreement to be acquired…
-
Oxford Biomedica transforms into a pure-play CDMO in cell and gene therapy
•
LONDON, UK: Oxford Biomedica, a leading cell and gene therapy CDMO, has announced a business update for the…
-
THG Plc agrees to acquire Biossance for a maximum $20 million
•
LONDON, UK: THG Plc has agreed to acquire prestige skincare brand Biossance for a maximum consideration of $20…
-
Oxford Biomedica signs deal to acquire of ABL Europe for €15 million
•
OXFORD, UK: Oxford Biomedica plc has entered into a sale and purchase agreement with TSGH SAS, a subsidiary…
-
AbbVie to buy ImmunoGen for $10.1 billion, boosting its oncology portfolio
•
AbbVie Inc. (NYSE: ABBV) announced today that it has agreed to acquire ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology…
-
Syncona Ltd to acquire all shares of Freeline Therapeutics at the rate of $6.5/share
•
LONDON, UK: Syncona Ltd’s newly established portfolio company has entered into an agreement with Freeline Therapeutics Holdings plc…
-
Starpharma Holdings appoints Cheryl Maley as Chief Executive Officer and Managing Director
•
MELBOURNE, AUSTRALIA: Starpharma Holdings (ASX: SPL) announced the appointment of Ms Cheryl Maley as Chief Executive Officer (CEO)…
-
AstraZeneca and Cellectis partner to accelerate development of next-generation therapeutics
•
LONDON, UK: AstraZeneca (NYSE: AZN) today announced a collaboration and investment agreement with Cellectis (NASDAQ: CLLS), a clinical-stage…
-
Roche buys Telavant for $7.1 billion, gains access to novel IBD drug
•
Roche, a Swiss pharmaceutical giant, has agreed to a US$7.1 billion deal to acquire Telavant, a biotech company…
-
Dimerix appoints former Race Oncology CMO Dr David Fuller
•
MELBOURNE, AUSTRALIA: Dimerix Limited (Dimerix), a biotechnology company developing novel treatments for kidney diseases, has announced the appointment…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.